Pharmaeconomica
The AI engine Fit Assessment
BetaPharmaeconomica effectively leverages machine learning and AI to discover new drug candidates, adapt to various therapeutic areas, and optimize the drug discovery process.
Blurb
Operator of an AI-enhanced physics-based drug discovery company headquartered in Oostende, Belgium. The company discovers and optimizes active, specific, non-toxic, and patentable small molecules delivering superior drug candidates, and combines artificial intelligence, computational chemistry, and peptide science to accelerate therapeutic compound discovery, streamline hit identification, and optimize leads.
HQ Location
Belgium
Founded
2012
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Operator of an AI-enhanced physics-based drug discovery company headquartered in Oostende, Belgium. The company discovers and optimizes active, specific, non-toxic, and patentable small molecules delivering superior drug candidates, and combines artificial intelligence, computational chemistry, and peptide science to accelerate therapeutic compound discovery, streamline hit identification, and optimize leads.